MENU
+Compare
CRON
Stock ticker: NASDAQ
AS OF
Jun 27 closing price
Price
$1.90
Change
-$0.01 (-0.52%)
Capitalization
1B

CRON Cronos Group Forecast, Technical & Fundamental Analysis

Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach... Show more

CRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CRON with price predictions
Jun 27, 2025

CRON sees its Stochastic Oscillator ascending out of oversold territory

On June 26, 2025, the Stochastic Oscillator for CRON moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 80 instances where the indicator left the oversold zone. In of the 80 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CRON advanced for three days, in of 206 cases, the price rose further within the following month. The odds of a continued upward trend are .

CRON may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 17, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CRON as a result. In of 108 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for CRON turned negative on May 27, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 54 similar instances when the indicator turned negative. In of the 54 cases the stock turned lower in the days that followed. This puts the odds of success at .

CRON moved below its 50-day moving average on June 18, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CRON crossed bearishly below the 50-day moving average on June 24, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRON declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CRON entered a downward trend on June 27, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.912) is normal, around the industry mean (62.813). P/E Ratio (0.000) is within average values for comparable stocks, (89.433). CRON's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.987). Dividend Yield (0.000) settles around the average of (0.124) among similar stocks. P/S Ratio (11.481) is also within normal values, averaging (19.290).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CRON’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRON’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
CRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CRON is expected to report earnings to 1 cents per share on August 07

Cronos Group CRON Stock Earnings Reports
Q2'25
Est.
$0.02
Q1'25
Beat
by $0.01
Q3'24
Beat
by $0.01
Q2'24
Missed
by $0.02
Q1'24
Est.
$-0.01
The last earnings report on May 08 showed earnings per share of 1 cents, beating the estimate of 0 cents. With 885.53K shares outstanding, the current market capitalization sits at 1.00B.
A.I. Advisor
published General Information

General Information

pharmaceutical, medical marijuana, cannabis

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
111 Peter Street
Phone
+1 416 504-0004
Employees
447
Web
https://www.thecronosgroup.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GAGCX33.740.33
+0.99%
Gabelli Global Rising Income and Div AAA
NWCCX43.010.27
+0.63%
Nuveen Winslow Large-Cap Growth ESG C
HICVX22.070.10
+0.46%
Hennessy Cornerstone Value Inst
VETAX45.300.12
+0.27%
Victory Sycamore Established Value A
CCVAX33.020.07
+0.21%
Calvert Small-Cap A

CRON and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CRON has been closely correlated with SNDL. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRON jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRON
1D Price
Change %
CRON100%
-0.52%
SNDL - CRON
73%
Closely correlated
-2.00%
TLRY - CRON
61%
Loosely correlated
-2.55%
OGI - CRON
59%
Loosely correlated
-3.57%
CGC - CRON
58%
Loosely correlated
-1.61%
ACB - CRON
56%
Loosely correlated
-2.58%
More

Groups containing CRON

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRON
1D Price
Change %
CRON100%
-0.52%
CRON
(2 stocks)
76%
Closely correlated
-0.67%
marijuana cannabis
(4 stocks)
71%
Closely correlated
-1.69%
north america
(185 stocks)
41%
Loosely correlated
-1.11%
pharmaceuticals
(152 stocks)
33%
Poorly correlated
-1.37%
Pharmaceuticals
(297 stocks)
19%
Poorly correlated
-0.03%
More